These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22893695)

  • 1. Influence of hormonal control on LH pulsatility and secretion in women with classical congenital adrenal hyperplasia.
    Bachelot A; Chakhtoura Z; Plu-Bureau G; Coudert M; Coussieu C; Badachi Y; Dulon J; Charbit B; Touraine P;
    Eur J Endocrinol; 2012 Oct; 167(4):499-505. PubMed ID: 22893695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the inappropriate gonadotropin secretion of patients with polycystic ovary syndrome similar to that of patients with adult-onset congenital adrenal hyperplasia?
    Levin JH; Carmina E; Lobo RA
    Fertil Steril; 1991 Oct; 56(4):635-40. PubMed ID: 1915936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
    Eagleson CA; Gingrich MB; Pastor CL; Arora TK; Burt CM; Evans WS; Marshall JC
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4047-52. PubMed ID: 11095431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11-oxygenated androgens and their relation to hypothalamus-pituitary-gonadal-axis disturbances in adults with congenital adrenal hyperplasia.
    Auer MK; Paizoni L; Neuner M; Lottspeich C; Schmidt H; Bidlingmaier M; Hawley J; Keevil B; Reisch N
    J Steroid Biochem Mol Biol; 2021 Sep; 212():105921. PubMed ID: 34058329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age effects of follicle-stimulating hormone and pulsatile luteinizing hormone secretion across the menstrual cycle of premenopausal women.
    Reame NE; Kelche RP; Beitins IZ; Yu MY; Zawacki CM; Padmanabhan V
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1512-8. PubMed ID: 8636360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of gonadotropin pulsatility in hirsute women with normal menstrual cycles and in women with polycystic ovary syndrome.
    Minanni SL; Marcondes JA; Wajchenberg BL; Cavaleiro AM; Fortes MA; Rego MA; Vezozzo DP; Robard D; Giannella-Neto D
    Fertil Steril; 1999 Apr; 71(4):675-83. PubMed ID: 10202878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.
    Arroyo A; Laughlin GA; Morales AJ; Yen SS
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3728-33. PubMed ID: 9360532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.
    Taylor AE; McCourt B; Martin KA; Anderson EJ; Adams JM; Schoenfeld D; Hall JE
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2248-56. PubMed ID: 9215302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase.
    Sagnella F; Apa R; Guido M; Villa P; Spadoni V; Miceli F; Lanzone A
    Fertil Steril; 2009 May; 91(5):1857-63. PubMed ID: 18538325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
    Pastor CL; Griffin-Korf ML; Aloi JA; Evans WS; Marshall JC
    J Clin Endocrinol Metab; 1998 Feb; 83(2):582-90. PubMed ID: 9467578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Ghizzoni L; Virdis R; Vottero A; Cappa M; Street ME; Zampolli M; Ibañez L; Bernasconi S
    J Clin Endocrinol Metab; 1996 Feb; 81(2):601-6. PubMed ID: 8636275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men.
    Vermeulen A; Kaufman JM; Deslypere JP; Thomas G
    J Clin Endocrinol Metab; 1993 May; 76(5):1140-6. PubMed ID: 8496304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age.
    Klein NA; Battaglia DE; Miller PB; Branigan EF; Giudice LC; Soules MR
    J Clin Endocrinol Metab; 1996 May; 81(5):1946-51. PubMed ID: 8626862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgens concentrations and second-to fourth-digit ratio (2D:4D) in girls with congenital adrenal hyperplasia (21-hydroxylase deficiency).
    Oswiecimska JM; Ksiazek A; Sygulla K; Pys-Spychala M; Roczniak GR; Roczniak W; Stojewska M; Ziora K
    Neuro Endocrinol Lett; 2012; 33(8):787-91. PubMed ID: 23391972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of long acting glucocorticoids on menstrual abnormalities in patients with virilizing congenital adrenal hyperplasia.
    Richards GE; Grumbach MM; Kaplan SL; Conte FA
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1208-15. PubMed ID: 233693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex Influence of Gonadotropins and Sex Steroid Hormones on QT Interval Duration.
    Abehsira G; Bachelot A; Badilini F; Koehl L; Lebot M; Favet C; Touraine P; Funck-Brentano C; Salem JE
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2776-84. PubMed ID: 27167057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
    Adams JM; Taylor AE; Crowley WF; Hall JE
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4343-50. PubMed ID: 15356031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The source of pulsatile secretion of progesterone during the human follicular phase.
    Judd S; Terry A; Petrucco M; White G
    J Clin Endocrinol Metab; 1992 Feb; 74(2):299-305. PubMed ID: 1730808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
    Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
    J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.